Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, Aβ 1–42 aggregation inhibitors and metal-chelating agents for Alzheimer's disease

Xu, Ping, Zhang, Minkui, Sheng, Rong, Ma, Yongmin·2017·European Journal of Medicinal Chemistry
DOI 10.1016/j.ejmech.2016.12.045

Cited by (105)

Items 101–105 of 105

  1. BindingDB Entry 50008218: Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease.
    BindingDB · 2021 · UC San Diego
  2. BindingDB Entry 50019344: Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease.
    BindingDB · 2024 · UC San Diego
  3. BindingDB Entry 50003064: Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer's disease.
    BindingDB · 2020 · UC San Diego
  4. BindingDB Entry 50012329: Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities.
    BindingDB · 2022 · UC San Diego
  5. BindingDB Entry 50018420: Synthesis and properties of the kojic acid dimer and its potential for the treatment of Alzheimer's disease.
    BindingDB · 2024 · UC San Diego